Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma

Banerjee, R., Richards, A., Midha, S., Afrough, A., Anwer, F., Atanackovic, D., Atrash, S., Bachanova, V., Beitinjaneh, A. M., Ouchveridze, E., Castaneda Puglianini, O., Chhabra, S., Cicero, K. I., Davis, J. A., Dhakal, B., Dima, D., Ferreri, C. J., Forsberg, P. A., Freeman, C. L., … Kaur, G. (2025). Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma. Blood Advances. https://doi.org/10.1182/bloodadvances.2025016131
Authors:
Rahul Banerjee
Alicia Richards
Shonali Midha
Aimaz Afrough
Faiz Anwer
Djordje Atanackovic
Shebli Atrash
Veronika Bachanova
Amer M Beitinjaneh
Evguenia Ouchveridze
Omar Castaneda Puglianini
Saurabh Chhabra
Kara I Cicero
James A Davis
Binod Dhakal
Danai Dima
Christopher J Ferreri
Peter A Forsberg
Ciara L Freeman
Megan M Herr
Tania Jain
Murali Janakiram
Jack Khouri
Mehmet Hakan Kocoglu
Anupama Deepa Kumar
Yuxin Liu
Frederick L Locke
Joseph P McGuirk
Lekha Mikkilineni
Omar Nadeem
Ricardo D Parrondo
Oren Pasvolsky
Lauren C Peres
Sneha Purvey
Shahzad Raza
Ran Reshef
Shambavi Richard
Adriana C Rossi
Douglas W Sborov
Leyla Shune
Charlotte B Wagner
Saurabh S Zanwar
Surbhi Sidana
Krina K Patel
Doris K Hansen
Shaji K Kumar
Yi Lin
Thomas G Martin
Peter M Voorhees
Larry D Anderson
Andrew J Cowan
Gurbakhash Kaur
Affiliated Authors:
Ran Reshef
Columbia Affiliation:
Subjects:
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Immunogenicity of Biosimilar Therapeutics in Drug Development (OpenAlex Topic)
Diagnosis and Treatment of Multiple Myeloma (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2025016131
PMID:
40088469
DOI:
10.1182/bloodadvances.2025016131
Journal:
Blood Advances
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record

Record Created: